# OWP PHARMACEUTICALS, INC. — Form D

OWP PHARMACEUTICALS, INC. of LISLE, IL, a company, filed a Form D exempt-offering notice with the SEC on 2025-09-09. The offering totals $2.4M, of which $2.4M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2025-09-09
- Form: D
- Accession: 0002037010-25-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.4M
- Amount sold: $2.4M
- Minimum investment: $25K
- Investors: 19
- Date of first sale: 2025-07-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-557097

## Issuer

- Name: OWP PHARMACEUTICALS, INC.
- CIK: 0002037010
- Entity type: Corporation
- Jurisdiction: ILLINOIS
- Address: 701 WARRENVILLE ROAD, LISLE, IL, 60532
- Phone: 847-722-0803

## Officers, directors & promoters (9)

| Name | Role | Location |
| --- | --- | --- |
| Scott Boyer | Director | Prosper, TX |
| BRUCE DUNCAN | Director | LISLE, IL |
| KURT FLORIAN | Director | LISLE, IL |
| TROY HAMMOND | Director | LISLE, IL |
| MATT LITFIN | Director | LISLE, IL |
| STEVE BOURNE | Executive Officer | LISLE, IL |
| Scott Boyer | Executive Officer | Prosper, TX |
| CAROL GAVIN | Director | NAPERVILLE, IL |
| PAUL REGAN | Director | NAPERVILLE, IL |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2024-09-16](https://search.stillhousedata.com/formd/0002037010-24-000001) | D | $2.7M | $2.7M |

## More

- [CIK 2037010 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2037010&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002037010-25-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.